These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22142615)

  • 1. Mefloquine-oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113.
    Gonçalves RS; Kaiser CR; Lourenço MC; Bezerra FA; de Souza MV; Wardell JL; Wardell SM; Henriques Md; Costa T
    Bioorg Med Chem; 2012 Jan; 20(1):243-8. PubMed ID: 22142615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives.
    Gonçalves RS; Kaiser CR; Lourenço MC; de Souza MV; Wardell JL; Wardell SM; da Silva AD
    Eur J Med Chem; 2010 Dec; 45(12):6095-100. PubMed ID: 20932608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection.
    Rodrigues-Junior VS; Villela AD; Gonçalves RS; Abbadi BL; Trindade RV; López-Gavín A; Tudó G; González-Martín J; Basso LA; de Souza MV; Campos MM; Santos DS
    Int J Antimicrob Agents; 2016 Aug; 48(2):203-7. PubMed ID: 27364701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine-oxazolidine derivatives: a new class of anticancer agents.
    Rodrigues FA; Bomfim Ida S; Cavalcanti BC; Pessoa C; Goncalves RS; Wardell JL; Wardell SM; de Souza MV
    Chem Biol Drug Des; 2014 Jan; 83(1):126-31. PubMed ID: 23961998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tuberculosis evaluation and conformational study of N-acylhydrazones containing the thiophene nucleus.
    Cardoso LN; Bispo ML; Kaiser CR; Wardell JL; Wardell SM; Lourenço MC; Bezerra FA; Soares RP; Rocha MN; de Souza MV
    Arch Pharm (Weinheim); 2014 Jun; 347(6):432-48. PubMed ID: 24616002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
    J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacious In Vitro and In Vivo Effects of Dihydrosphingosine-Ethambutol Analogues Against Susceptible and Multi-drug-resistant Mycobacterium tuberculosis.
    Olmo ED; Molina-Salinas GM; Bini EI; González-Hernández S; Bustos LA; Escarcena R; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; González-Ramírez D; Fernández SS; San Feliciano A; Hernández-Pando R
    Arch Med Res; 2016 May; 47(4):262-70. PubMed ID: 27664485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
    Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols.
    Shaharyar M; Ali MA; Bakht MA; Murugan V
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):432-6. PubMed ID: 18569351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
    Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
    Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
    Sood R; Rao M; Singhal S; Rattan A
    Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates.
    Rey-Jurado E; Tudó G; de la Bellacasa JP; Espasa M; González-Martín J
    Int J Antimicrob Agents; 2013 Mar; 41(3):278-80. PubMed ID: 23312604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A; Soltani F
    Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
    Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
    Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.